These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33218953)

  • 1. Assessment of serum periostin level as a predictor of requirement for intensive treatment for type-2 inflammation in asthmatics in future: A follow-up study of the KiHAC cohort.
    Sunadome H; Matsumoto H; Tohda Y; Horiguchi T; Kita H; Kuwabara K; Tomii K; Otsuka K; Fujimura M; Ohkura N; Iwanaga T; Hozawa S; Niimi A; Kanemitsu Y; Nagasaki T; Tashima N; Ishiyama Y; Morimoto C; Oguma T; Tajiri T; Ito I; Ono J; Ohta S; Izuhara K; Hirai T
    Allergol Int; 2021 Apr; 70(2):252-254. PubMed ID: 33218953
    [No Abstract]   [Full Text] [Related]  

  • 2. Longitudinal variation of serum periostin levels in adults with stable asthma.
    Semprini R; Caswell-Smith R; Fingleton J; Holweg C; Matthews J; Weatherall M; Beasley R; Braithwaite I;
    J Allergy Clin Immunol; 2017 May; 139(5):1687-1688.e9. PubMed ID: 28093216
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum periostin levels serve as a biomarker for both eosinophilic airway inflammation and fixed airflow limitation in well-controlled asthmatics.
    Takahashi K; Meguro K; Kawashima H; Kashiwakuma D; Kagami SI; Ohta S; Ono J; Izuhara K; Iwamoto I
    J Asthma; 2019 Mar; 56(3):236-243. PubMed ID: 29648484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum periostin: a novel biomarker for asthma management.
    Matsumoto H
    Allergol Int; 2014 Jun; 63(2):153-60. PubMed ID: 24759559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using exhaled nitric oxide and serum periostin as a composite marker to identify severe/steroid-insensitive asthma.
    Nagasaki T; Matsumoto H; Kanemitsu Y; Izuhara K; Tohda Y; Horiguchi T; Kita H; Tomii K; Fujimura M; Yokoyama A; Nakano Y; Hozawa S; Ito I; Oguma T; Izuhara Y; Tajiri T; Iwata T; Ono J; Ohta S; Yokoyama T; Niimi A; Mishima M
    Am J Respir Crit Care Med; 2014 Dec; 190(12):1449-52. PubMed ID: 25496105
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids.
    Kanemitsu Y; Matsumoto H; Izuhara K; Tohda Y; Kita H; Horiguchi T; Kuwabara K; Tomii K; Otsuka K; Fujimura M; Ohkura N; Tomita K; Yokoyama A; Ohnishi H; Nakano Y; Oguma T; Hozawa S; Nagasaki T; Ito I; Oguma T; Inoue H; Tajiri T; Iwata T; Izuhara Y; Ono J; Ohta S; Tamari M; Hirota T; Yokoyama T; Niimi A; Mishima M
    J Allergy Clin Immunol; 2013 Aug; 132(2):305-12.e3. PubMed ID: 23791506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of inhaled corticosteroids on serum periostin levels in adult patients with mild-moderate asthma.
    Solanki B; Prakash A; Rehan HS; Gupta LK
    Allergy Asthma Proc; 2019 Jan; 40(1):32-34. PubMed ID: 30582493
    [No Abstract]   [Full Text] [Related]  

  • 8. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients.
    Jia G; Erickson RW; Choy DF; Mosesova S; Wu LC; Solberg OD; Shikotra A; Carter R; Audusseau S; Hamid Q; Bradding P; Fahy JV; Woodruff PG; Harris JM; Arron JR;
    J Allergy Clin Immunol; 2012 Sep; 130(3):647-654.e10. PubMed ID: 22857879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of serum periostin and free IgE levels in evaluating responsiveness to omalizumab in patients with severe asthma.
    Tajiri T; Matsumoto H; Gon Y; Ito R; Hashimoto S; Izuhara K; Suzukawa M; Ohta K; Ono J; Ohta S; Ito I; Oguma T; Inoue H; Iwata T; Kanemitsu Y; Nagasaki T; Niimi A; Mishima M
    Allergy; 2016 Oct; 71(10):1472-9. PubMed ID: 27113353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum periostin during omalizumab therapy in asthma: A tool for patient selection and treatment evaluation.
    Caminati M; Gatti D; Dama A; Lorenzetti L; Senna G
    Ann Allergy Asthma Immunol; 2017 Nov; 119(5):460-462. PubMed ID: 28941707
    [No Abstract]   [Full Text] [Related]  

  • 11. Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial.
    Heaney LG; Busby J; Hanratty CE; Djukanovic R; Woodcock A; Walker SM; Hardman TC; Arron JR; Choy DF; Bradding P; Brightling CE; Chaudhuri R; Cowan DC; Mansur AH; Fowler SJ; Niven RM; Howarth PH; Lordan JL; Menzies-Gow A; Harrison TW; Robinson DS; Holweg CTJ; Matthews JG; Pavord ID;
    Lancet Respir Med; 2021 Jan; 9(1):57-68. PubMed ID: 32916135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High density lipoproteins and type 2 inflammatory biomarkers are negatively correlated in atopic asthmatics.
    Barochia AV; Gordon EM; Kaler M; Cuento RA; Theard P; Figueroa DM; Yao X; Weir NA; Sampson ML; Stylianou M; Choy DF; Holweg CTJ; Remaley AT; Levine SJ
    J Lipid Res; 2017 Aug; 58(8):1713-1721. PubMed ID: 28655726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum periostin in smokers and never smokers with asthma.
    Thomson NC; Chaudhuri R; Spears M; Haughney J; McSharry C
    Respir Med; 2015 Jun; 109(6):708-15. PubMed ID: 25869478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of treatment with inhaled corticosteroid on serum periostin levels in asthma.
    Hoshino M; Ohtawa J; Akitsu K
    Respirology; 2016 Feb; 21(2):297-303. PubMed ID: 26607392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alveolar nitric oxide concentration, small airways inflammation, and targeted asthma therapy: are we there yet?
    Kelly HW
    J Allergy Clin Immunol; 2010 Oct; 126(4):736-7. PubMed ID: 20920762
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent developments regarding periostin in bronchial asthma.
    Izuhara K; Matsumoto H; Ohta S; Ono J; Arima K; Ogawa M
    Allergol Int; 2015 Sep; 64 Suppl():S3-10. PubMed ID: 26344077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between serum periostin and a type 2 helper airway composite index in optimally treated asthmatics.
    Konstantellou E; Loukides S; Ntontsi P; Papathanasiou E; Kostikas K; Paptheodorou G; Hillas G; Papiris S; Koulouris NG; Bakakos P
    J Allergy Clin Immunol Pract; 2017; 5(4):1129-1131.e3. PubMed ID: 28396112
    [No Abstract]   [Full Text] [Related]  

  • 18. Roles of Periostin in Asthma.
    Matsumoto H
    Adv Exp Med Biol; 2019; 1132():145-159. PubMed ID: 31037633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum but not exhaled breath condensate periostin level is increased in competitive athletes.
    Kurowski M; Jurczyk J; Jarzębska M; Wardzyńska A; Krysztofiak H; Kowalski ML
    Clin Respir J; 2018 May; 12(5):1919-1926. PubMed ID: 29316316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of serum periostin and YKL40 in children with severe asthma and asthma exacerbation.
    El Basha NR; Osman HM; Abdelaal AA; Saed SM; Shaaban HH
    J Investig Med; 2018 Dec; 66(8):1102-1108. PubMed ID: 29970479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.